Project Grant HT94252510506
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$718K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92037, USA
Similar Awards
The U.S. Department of Defense, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $1,104,000.00 Project Grant to the Scripps Research Institute in La Jolla, California. The grant, titled "TUMOR-TARGETED NANOCARRIERS FOR EFFECTIVE IMMUNOMODULATION OF OVARIAN CANCER," will fund research focused on developing innovative, tumor-targeted nanocarriers to effectively modulate the immune response for the treatment of ovarian cancer. The...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded Scripps Research Institute, a nonprofit biomedical research organization, a $529,125 project grant to investigate microglia dysfunction in MEF2C deficiency autism spectrum disorder with the goal of discovering targeted therapies. This 3-year award, effective September 30, 2024, will fund research aimed at improving the health and care of military service members, veterans, and their families...
The Sloan-Kettering Institute For Cancer Research was awarded a $1,593,000 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) on September 30, 2022. The grant-funded project will investigate ceramide's role in mediating COVID-19 vascular injury and acute respiratory distress syndrome through basic, applied, and advanced biomedical research. Specifically, the Institute will conduct research to develop medical solutions...
The Defense Health Agency awarded a $1,116,955 Project Grant to The Broad Institute, Inc. to identify new therapies and therapeutic targets in gastroesophageal cancer. This 3-year grant, running from August 15, 2023 to August 14, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). The Broad Institute, a non-profit biomedical and genomic research organization, will leverage its expertise in areas like genomic sequencing, data analysis, and translational...
The Department of Defense's Defense Health Agency has awarded a $1,344,002 Project Grant to Cold Spring Harbor Laboratory (CSHL) under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, running from August 1, 2024 to July 31, 2028, will fund research to enhance immunity in colorectal cancer liver metastases. CSHL, a renowned non-profit research institution, will leverage its expertise in cancer biology, genomics, and molecular biology to advance this...
The U.S. Department of Defense's Defense Health Agency awarded a $752,000 Project Grant to The Institute For Cancer Research, a subsidiary of Temple University, to investigate therapeutic response disparities in locally advanced rectal cancer. This grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform health care for service members and the public through innovative and impactful research....
This federal Project Grant award, valued at $1,078,882.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research project conducted by the Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, CA. The project aims to investigate a "chemical engineering approach to ALS that amplifies a more sophisticated view of the multimodal therapeutic actions of donor and host neural stem cells in that...
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), provides $3,333,240.00 to the Allegheny Singer Research Institute to fund research on the effects of intracavitary conditioning in breast cancer metastatic to the pleura or peritoneum. The award period runs from June 1, 2025 to May 31, 2029. The research aims to explore innovative approaches to the prevention, diagnosis, treatment, and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,774,998.00 to the Coriell Institute for Medical Research, Inc., a non-profit biomedical research center, to conduct research on exosomal galectin-3 mediated stromal activation and immunosuppression in advanced gastric adenocarcinoma. The award, effective from September 30, 2024 to September 29, 2027, supports the institute's innovative scientific...
The project grant award of $880,000 is funded by the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant is awarded to the Sloan-Kettering Institute for Cancer Research to conduct research on using interferon E as a tumor suppressor and potential therapeutic for pancreatic cancer. The project will take place over a 3-year period from September 1, 2024 to August 31, 2027. As a leading comprehensive cancer...